Not all patients with CLL require therapy. Regardless of all the latest advancements, the iwCLL however suggests watchful observation for individuals with asymptomatic disorder.86 This advice relies on at the least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Na